M-RCBG Senior Fellow-Led Study Group: Omar Robles
Innovation and Competition for Life-Saving Drugs: Balancing Hatch-Waxman and Biologics Price, Competition and Innovation Acts
Thursday, November 17 4:30-6:00
Wexner 102 (Heng Conference Room)
M-RCBG Senior Fellow Omar Robles will host Sanya Sukduang and Jonathan Davies to discuss U.S. policies promoting the development of novel life-saving drugs while simultaneously increasing accessibility. The panel will address the policy considerations that gave rise to Hatch-Waxman and the BPCIA, how those considerations have played out in practice, and whether the statutory schemes have achieved their goals.
Participants bios:
Omar Robles is Managing Partner at Emerging Health LLC, a consulting firm dedicated to applying economic and strategic expertise to complex business and legal challenges in life sciences. Dr. Robles has consulted on numerous commercial litigations concerning prescription pharmaceuticals, medical devices, and dietary supplements. His engagements have concerned antitrust claims and intellectual property matters litigated in US federal and state courts, the US Patent Trial and Appeal Board, and Canadian courts. Dr. Robles’ research focuses on regulatory health policy, drug development, and competition in life sciences. His work has been published in peer-reviewed journals such as the American Economic Journal: Applied Economics and the Journal of Health Economics. In addition, Dr. Robles routinely publishes articles in legal news sources as a life sciences expert and has contributed to multiple publications from the American Bar Association. He also holds a Lecturer position at the University of California Berkeley School of Public Health where he provides graduate instruction on regulatory science and drug development. He has previously taught economics and public policy at Harvard University, Georgetown University, and the University of Maryland-College Park. In 2010, Dr. Robles received the prestigious Joseph R. Levenson Memorial Teaching Prize for excellence in teaching from the Harvard Undergraduate Council. Dr. Robles received his B.B.A. in finance and economics from the University of Wisconsin-Madison, his M.B.A. from DePaul University, and his M.A. and Ph.D. in economics from Harvard University. As a Senior Fellow, his research will focus on the role of regulatory policy on competition in prescription pharmaceuticals. Email: orobles@hks.harvard.edu